HR 919: Chronic Disease Flexible Coverage Act
HR 919 in plain English: This bill gives permanent legal backing to existing IRS guidance that allows high-deductible health plans (HDHPs) to cover certain chronic disease treatments—such as medications for heart disease, diabetes, asthma, and depression—without requiring patients to first meet their deductible, while still keeping the plan eligible for use with a health savings account (HSA).
Stated purpose
This bill gives permanent legal standing to existing IRS guidance that allows high-deductible health plans to cover certain medications and services for chronic conditions — such as diabetes, heart disease, asthma, and depression — before the deductible is met, so that people with these conditions can use a health savings account while still getting affordable access to their treatments.
Key points
- Lets HDHPs cover specific chronic disease medications and tests before the deductible is met, without losing HSA eligibility.
- Covered items include insulin, statins, blood pressure monitors, inhalers, and antidepressants for qualifying conditions.
- Applies to patients with conditions such as diabetes, heart disease, asthma, osteoporosis, and depression.
- Converts existing IRS administrative guidance into a formal federal statute.
Arguments supporters make
- People managing serious chronic conditions like diabetes or heart disease should not have to choose between affording their ongoing medications and keeping their health savings account — this bill removes that barrier.
- The IRS guidance this bill codifies has already been in use since 2019; making it permanent law gives patients and employers long-term certainty instead of relying on guidance that could be reversed at any time.
- Early and consistent treatment of chronic diseases can prevent costly complications, which is good for patients and may reduce overall health care spending.
Arguments opponents make
- Codifying only this specific list of conditions and treatments into law makes it harder to update coverage as medicine evolves, locking in today's choices and potentially leaving out new therapies or conditions in the future.
- Allowing pre-deductible coverage expands what counts as 'preventive care' beyond its original meaning, which critics say could gradually erode the high-deductible structure that makes HSAs work as intended and encourages cost-conscious health decisions.
- The bill addresses a narrow set of conditions and treatments, meaning many people with other serious chronic illnesses receive no similar benefit, raising questions about why some conditions are prioritized over others.
Tradeoffs
Making chronic disease treatments more affordable and accessible for HDHP enrollees comes at the cost of reducing the cost-sharing structure that high-deductible plans are designed to encourage; the law also trades flexibility for certainty by fixing a specific list in statute rather than leaving it to ongoing regulatory updating.
Current status in Congress: Passed House.
NewsClear — neutral news & congressional tracking · Bill of the Week